Your session is about to expire
← Back to Search
N-Acetyl cysteine for Biliary Atresia
Study Summary
This trial is testing whether N-acetylcysteine can improve bile flow after Kasai portoenterostomy in infants with biliary atresia.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My liver is not working well even after Vitamin K treatment.I do not have severe illnesses that could affect the study's outcome.I am 90 days old or younger.I currently have a respiratory infection.I did not undergo KP due to specific reasons during surgery.My kidney function is reduced with eGFR or creatinine clearance below 60 mL/min.
- Group 1: N-Acetylcysteine Treatment
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many volunteers are taking part in this research project?
"This clinical study is no longer recruiting participants. Originally posted on May 18th 2018, it was last updated on August 1st 2022. If searching for other trials, there are currently 12 studies enrolling patients with biliary atresia and 24 involving N-Acetyl cysteine."
Is N-Acetyl cysteine a consequence-free supplement?
"Our team rated N-Acetyl cysteine with a score of 2 since it is still in its second clinical phase, suggesting that while safety information exists, there are not yet any results confirming its efficacy."
Are there any unfilled openings in this research program?
"Per the information held on clinicaltrials.gov, this specific medical trial is not actively seeking participants at present. Initially posted on May 18th 2018 and last updated August 1st 2022, it has already concluded its recruitment process; however, there are 36 other studies with open enrolment opportunities available now."
What eligibility criteria have been established for potential participants in this clinical investigation?
"This clinical study is soliciting 16 infants between 0 and 90 days old with a biliary atresia diagnosis confirmed by cholangiography, who have had their Kasai procedure performed at Texas Children's Hospital in the Texas Medical Center. The legal guardian(s) must also agree to participate after being informed of all associated risks and understand that this trial is experimental in nature."
Is participation in this medical research restricted to individuals over a certain age?
"This clinical trial is specifically seeking out participants aged 0 days to 90 days. For those outside of the specified age range, there are 18 trials targeting people under 18 and 20 for seniors over 65."
Share this study with friends
Copy Link
Messenger